The company's balance sheet remains robust with $757 million in cash and cash equivalents as of December 31, 2023, although this represents a decrease from $854 million at the end of 2022. Teradyne's ability to maintain a strong cash position despite the revenue decline is a testament to its financial resilience and operational efficiency.